NIH-funded study finds progression of eye growth returns to normal in older teens, with no loss of treatment benefit.

A new report shows the benefit of wearing contact lenses for slowing myopia has a lasting effect -- good news since 50% of the world (5 billion people) will likely be nearsighted by 2050.

That brings the total to 25 drugs that will have lower price tags, which account for a third of Medicare spending on ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Soft multifocal lens treatment for myopia can be discontinued in the later teenage years without a rebound effect.

Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.